CORT - Corcept Therapeutics Incorporated
10.48 0.00 (0.00%)
After hours: 4:38PM EDT
| Previous Close | 10.20 |
| Open | 10.13 |
| Bid | 9.98 x 2900 |
| Ask | 11.25 x 1300 |
| Day's Range | 10.00 - 10.52 |
| 52 Week Range | 9.14 - 20.00 |
| Volume | 718,437 |
| Avg. Volume | 860,475 |
| Market Cap | 1.204B |
| Beta (3Y Monthly) | 1.28 |
| PE Ratio (TTM) | 17.18 |
| EPS (TTM) | 0.61 |
| Earnings Date | Aug 7, 2019 - Aug 12, 2019 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 14.50 |
- ACCESSWIRE•3 days ago
Lawsuit for Investors in shares of Corcept Therapeutics Incorporated (NASDAQ: CORT) announced by Shareholders Foundation
SAN DIEGO, CA / ACCESSWIRE / May 20, 2019 / The Shareholders Foundation, Inc. announces that a lawsuit was filed for certain investors in Corcept Therapeutics Incorporated (NASDAQ: CORT) shares. Investors, ...
- Thomson Reuters StreetEvents•4 days ago
Edited Transcript of CORT earnings conference call or presentation 9-May-19 9:00pm GMT
Q1 2019 Corcept Therapeutics Inc Earnings Call
- GlobeNewswire•7 days ago
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Corcept, Mobile TeleSystems, Healthcare Services, and American Renal and Encourages Investors to Contact the Firm
NEW YORK, May 16, 2019 -- Bragar Eagel & Squire, P.C. reminds investors that class action lawsuits have been commenced on behalf of stockholders of Corcept Therapeutics.
- GlobeNewswire•10 days ago
CRBP, NIO & CORT Deadline Alert - Bronstein, Gewirtz & Grossman, LLC Class Action
NEW YORK, May 13, 2019 -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following.
- Business Wire•10 days ago
DEADLINE MONDAY REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Corcept Therapeutics Incorporated and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Corcept Therapeutics Incorporated (“Corcept” or “the Company”) (NASDAQ: CORT) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
- GlobeNewswire•10 days ago
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of CORT, HCSG, BA and NOK
NEW YORK, May 13, 2019 -- The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss.
- GlobeNewswire•10 days ago
DEADLINE TODAY: Rosen Law Firm Reminds Corcept Therapeutics Incorporated Investors of Important May 13th Deadline in Securities Class Action Lawsuit - CORT
NEW YORK, May 13, 2019 -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Corcept Therapeutics Incorporated (NASDAQ: CORT) from.
- GlobeNewswire•11 days ago
INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In NIO, CORT, HCSG or FCHS To Contact The Firm
NEW YORK, May 12, 2019 -- Faruqi & Faruqi, LLP, a leading national securities law firm, encourages investors in the following companies to contact the firm: Company:.
- ACCESSWIRE•13 days ago
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of CORT, FSNN and BSX
NEW YORK, NY / ACCESSWIRE / May 10, 2019 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have ...
- ACCESSWIRE•13 days ago
3-Day Deadline Alert: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Corcept Therapeutics Incorporated and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / May 10, 2019 / The Schall Law Firm , a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Corcept Therapeutics Incorporated ...
- ACCESSWIRE•13 days ago
CLASS ACTION UPDATE for CORT, FSNN and MWA: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
NEW YORK, NY / ACCESSWIRE / May 10, 2019 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested ...
- GlobeNewswire•13 days ago
DEADLINE MONDAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Corcept Therapeutics Incorporated and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Corcept Therapeutics Incorporated (“Corcept” or “the Company”) (NASDAQ: CORT) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. You can also reach us through the firm's website at www.schallfirm.com, or by email at brian@schallfirm.com.
Motley Fool•13 days agoCorcept Therapeutics Incorporated (CORT) Q1 2019 Earnings Call Transcript
CORT earnings call for the period ending March 31, 2019.
- Zacks•14 days ago
Corcept Therapeutics (CORT) Q1 Earnings Top Estimates
Corcept (CORT) delivered earnings and revenue surprises of 11.11% and -3.96%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
- Associated Press•14 days ago
Corcept: 1Q Earnings Snapshot
The Menlo Park, California-based company said it had net income of 15 cents per share. Earnings, adjusted for non-recurring costs, were 20 cents per share. The drug developer posted revenue of $64.8 million ...
- ACCESSWIRE•14 days ago
CLASS ACTION UPDATE for CORT, NIO and BSX: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
NEW YORK, NY / ACCESSWIRE / May 9, 2019 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested ...
- GlobeNewswire•14 days ago
Deadline Reminder: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Corcept Therapeutics Incorporated
Law Offices of Howard G. Smith reminds investors of the upcoming May 13, 2019 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased Corcept Therapeutics Incorporated (“Corcept” or the “Company”) (NASDAQ: CORT) securities between August 2, 2017 and February 5, 2019, inclusive (the “Class Period”). Investors suffering losses on their Corcept investments are encouraged to contact the Law Offices of Howard G. Smith to discuss their legal rights in this class action at 888-638-4847 or by email to howardsmith@howardsmithlaw.com.
- GlobeNewswire•14 days ago
Corcept Therapeutics Announces First Quarter 2019 Financial Results and Provides Corporate Update
MENLO PARK, Calif., May 09, 2019 -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of drugs to treat.
- ACCESSWIRE•14 days ago
LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Corcept Therapeutics Incorporated To Contact The Firm
NEW YORK, NY / ACCESSWIRE / May 9, 2019 / Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Corcept Therapeutics Incorporated ("Corcept" or the "Company") (CORT) of the May 13, 2019 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. You can also contact us by calling Richard Gonnello toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to rgonnello@faruqilaw.com.
- GlobeNewswire•14 days ago
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Corcept Therapeutics Incorporated - CORT
Pomerantz LLP is investigating claims on behalf of investors of Corcept Therapeutics Incorporated (“Corcept” or the “Company”) (NASDAQ: CORT). Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext.
- ACCESSWIRE•14 days ago
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of CORT, FSNN and APYX
NEW YORK, NY / ACCESSWIRE / May 9, 2019 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have ...
- ACCESSWIRE•14 days ago
4-Day Deadline Alert: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Corcept Therapeutics Incorporated and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / May 9 2019 / The Schall Law Firm , a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Corcept Therapeutics Incorporated ...
- GlobeNewswire•14 days ago
CLASS ACTION UPDATE for CORT, NIO, MBT and NOK: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
NEW YORK, May 09, 2019 -- Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies..
